Related Experiment Video
Updated: Mar 17, 2026

07:57
Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
4.9K
[Hypertriglyceridemia and ischemic heart disease: Is a risk factor ?]
Summary
This study found no significant difference in triglyceride levels between patients with and without coronary cardiovascular disease (CVD). Elevated triglycerides are not definitively linked to increased CVD risk in this patient cohort.
Area of Science:
- Cardiology
- Lipid Metabolism
- Public Health
Background:
- Hypercholesterolemia is a known risk factor for coronary cardiovascular disease (CVD).
- The association between triglyceride levels and CVD risk is debated.
- Understanding lipid profiles is crucial for cardiovascular risk assessment.
Purpose of the Study:
- To investigate triglyceride levels in patients with and without CVD.
- To examine the relationship between triglycerides, cholesterol, HDL, LDL, obesity, and overweight.
- To clarify the role of triglycerides in cardiovascular risk.
Main Methods:
- Retrospective study of 100 patients (30-60 years old) between January and December 2009.
- Included patients with and without CVD from Córdoba Hospital and Clínica Sucre.
- Compared lipid profiles, including triglycerides, HDL, and LDL cholesterol, between CVD and control groups.
Main Results:
- No statistically significant differences in lipid values were observed between groups.
- Triglyceride levels were slightly higher in the control group, but not statistically significant (p=0.7162).
- The study included 64 patients with CVD and 36 controls, with 74% males and 68% over 50 years old.
Conclusions:
- Triglyceride levels did not show a statistically significant elevation in patients with CVD.
- The findings suggest that triglycerides may not be a primary risk factor for CVD in this population.
- Further research is needed to fully elucidate the complex role of triglycerides in cardiovascular health.
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
762
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
762
Ischemic Heart Disease: Overview
3.8K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.8K
Atherosclerosis III: Management
567
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
567
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.7K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Overview of Lipid Metabolism
6.5K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.5K
Coronary Artery Disease I: Introduction
1.5K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.5K

